Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

DIABETES

Treating T2DM by ensuring insulin access is a global challenge

Nature Reviews Endocrinology volume 15, pages 135–137 (2019)Cite this article

Subjects

As the global increase in type 2 diabetes mellitus has a steep upward slope, meeting the worldwide demand for insulin is an international challenge. Sanjay Basu and colleagues used microsimulation to create scenarios that can inform the design of health-care strategies and insulin requirements for governments and the national and international organizations responsible for formulating treatment guidelines.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Disability weighting.

References

  1. International Diabetes Federation. IDF Diabetes Atlas 8th edn (International Diabetes Federation, 2017).

  2. Utumatwishima, J. N. et al. Reversing the tide - diagnosis and prevention of T2DM in populations of African descent. Nat. Rev. Endocrinol. 14, 45–56 (2018).

    Article  Google Scholar 

  3. Basu, S., Shankar, V. & Yudkin, J. S. Comparative effectiveness and cost-effectiveness of treat-to-target versus benefit-based tailored treatment of type 2 diabetes in low-income and middle-income countries: a modelling analysis. Lancet Diabetes Endocrinol. 4, 922–932 (2016).

    Article  Google Scholar 

  4. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352, 837–853 (1998).

    Article  Google Scholar 

  5. Al-Rifai, R. H. et al. Association between diabetes mellitus and active tuberculosis: a systematic review and meta-analysis. PLOS ONE 12, e0187967 (2017).

    Article  Google Scholar 

  6. Owens, D. R. Clinical evidence for the earlier initiation of insulin therapy in type 2 diabetes. Diabetes Technol. Ther. 15, 776–785 (2013).

    Article  CAS  Google Scholar 

  7. Basu, S. et al. Estimation of global insulin use for type 2 diabetes, 2018-30: a microsimulation analysis. Lancet Diabetes Endocrinol. 7, 25–33 (2018).

    Article  Google Scholar 

  8. Rutter, C. M., Zaslavsky, A. M. & Feuer, E. J. Dynamic microsimulation models for health outcomes: a review. Med. Decis. Making 31, 10–18 (2011).

    Article  Google Scholar 

  9. Salomon, J. A. et al. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet 380, 2129–2143 (2012).

    Article  Google Scholar 

  10. CantyMedia. The world: life expectancy — Top 100+. geoba.se http://www.geoba.se/population.php?pc=world&type=015&year=2018&st=country&asde=&page=1 (2018).

Download references

Acknowledgements

M.F.H-R. and A.E.S. are supported by the intramural programme of the National Institute of Diabetes, Digestive and Kidney Diseases and the NIH. In addition, A.E.S. is supported by the intramural programme of the National Institute of Minority Health and Health Disparities and the NIH.

Author information

Authors and Affiliations

  1. Section on Ethnicity and Health, Diabetes, Endocrinology and Obesity Branch, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA

    Margrethe F. Horlyck-Romanovsky & Anne E. Sumner

  2. National Institute of Minority Health and Health Disparities, National Institutes of Health, Bethesda, MD, USA

    Anne E. Sumner

Authors
  1. Margrethe F. Horlyck-Romanovsky
    View author publications

    Search author on:PubMed Google Scholar

  2. Anne E. Sumner
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Anne E. Sumner.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Horlyck-Romanovsky, M.F., Sumner, A.E. Treating T2DM by ensuring insulin access is a global challenge. Nat Rev Endocrinol 15, 135–137 (2019). https://doi.org/10.1038/s41574-019-0160-3

Download citation

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41574-019-0160-3

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing